#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Granulomatosis with polyangiitis Neoplasm Fabry's disease Arginase deficiency Oesophageal adenocarcinoma Netherton's syndrome Cholestatic pruritus Desmoplastic small round cell tumour Piriformis syndrome Rheumatoid arthritis Ataxia telangiectasia Biliary neoplasm Pancreatic carcinoma Epileptic encephalopathy Behcet's syndrome More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Trials in Disease Langerhans’ cell histiocytosis – Trials in Disease Hepatic angiosarcoma – Life with Disease Medulloblastoma – Basic Information Lymphangioma – Diagnostics Usher’s syndrome Thrombotic thrombocytopenic purpura Primary immunodeficiency syndrome – Treatment Waldenstrom’s macroglobulinaemia – Life with Disease Andersen-Tawil syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Water For Injection Stiripentol Maridebart Cafraglutide Fingolimod Zinc Sulphate Heptahydrate VOXVOGANAN Naxitamab MAPLIRPACEPT Efgartigimod Alfa PEGZILARGINASE Clascoterone Deferoxamine Nvdx3 Elezanumab Alendronic Acid DISODIUM PHOSPHATE Transcon Il-2Β/Γ Azd0305 Allo-647 Bi 1819479 More therapies…

    Learn about Your Condition

    Frostbite Coronary artery occlusion Arterial disorder Cervix carcinoma stage II Small for dates baby Albright's disease Lung disorder Endometrial cancer stage II Dupuytren's contracture Mantle cell lymphoma recurrent Skin angiosarcoma Viral myocarditis Malignant oligodendroglioma Cerebral amyloid angiopathy Triple negative breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Spitalul Clinic Coltea

Spitalul Clinic Coltea

Bulevardul Bratianu C. Ion 1-3, Bucharest, 030171, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Rituximab
    Czechia France Poland Romania Spain

  • Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Imatinib
    • Asciminib Hydrochloride
    • Bosutinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Finland France +10

  • QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute promyelocytic leukaemia
    Investigated Drugs:
    • Arsenic Trioxide
    France Germany Italy Poland Romania Spain

  • A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Acalabrutinib
    • Venetoclax
    Czechia France Germany Italy The Netherlands Poland +3

  • A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

    Recruiting

    2 1
    Investigated Drugs:
    • VAMIFEPORT TRIHYDROCHLORIDE
    Austria Belgium Czechia France Germany Ireland +5

  • A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • HLX43
    France Italy Poland Romania Spain

  • A Study to Evaluate LY3537021 and a Drug Combination for Treating Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Vomiting
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Ondansetron Hydrochloride
    • LY3537021
    • Aprepitant
    France Italy Romania Spain

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer metastatic
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • BNT327
    • Etoposide
    • Atezolizumab
    France Germany Italy The Netherlands Poland Romania +1

  • Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Revumenib
    • Idarubicin Hydrochloride
    • Daunorubicin Hydrochloride
    Austria Belgium Czechia France Germany Greece +7
1 2 3 … 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!